Beam Therapeutics Announces Positive Data in Trial Demonstrating First Ever Clinical Genetic Correction of a Disease-causing Mutation
On Mar. 10, 2025, Beam Therapeutics announced initial safety and efficacy data from its Phase 1/2 trial of…
Revvity’s EUROIMMUN Receives CE Mark for Novel Measles Antibody Detection Assay
On Mar. 3, 2025, Revvity announced the launch of EUROIMMUN’s CE-marked Anti-Measles Virus ELISA 2.0 (IgG) to support…
New hybrid custom-designed Microscope Can Image Full 3D Orientation & Position of Molecules in Cells
On Feb. 21, 2025, a team of researchers from the Marine Biological Laboratory (MBL) announced a hybrid custom-designed…
Hologic Announces FDA Clearance of Aptima SARS-CoV-2 Assay
On Feb. 18, 2025, Hologic announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance…
Novartis acquires Anthos Therapeutics and late-stage cardiovascular pipeline for USD $3.1 billion
On Feb. 11, 2025, Novartis announced an agreement to acquire Anthos Therapeutics, a Boston-based, privately held, clinical-stage biopharmaceutical…
Mutations in two gene pairs point to a promising drug target in 5 percent of adult cancers
On Feb. 5, 2025, scientists from the Cancer Dependency Map (DepMap) at the Broad Institute of MIT and…
FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain
On Jan. 30, 2025, the U.S. Food and Drug Administration (FDA) approved Vertex Pharmaceuticals’s Journavx (suzetrigine) 50 milligram…
A genome-wide atlas of cell morphology revealed gene functions
On Jan. 27, 2025, researchers at the Broad Institute of MIT and Harvard, along with collaborators at Calico…
PET probe images inflammation with high sensitivity and selectivity
On Jan. 22, 2025, researchers at Dana-Farber Cancer Institute announced they have developed a breakthrough method to detect…
Massachusetts General Hospital Received Transformational Gift of $100 Million from Herb Chambers to Revolutionize Cancer Care for Patients and Families
On Dec. 11, 2024, Massachusetts General Hospital (MGH), founding member of the Mass General Brigham healthcare system, announced…
AquaBounty Announced Plans to Cease Fish Farming Operations
On Dec. 11, 2024 the Board of Directors of AquaBounty Technologies announced that the Company was winding down…
Massachusetts Governor Announced More than $21 Million in Tax Incentives for 19 Life Sciences Companies
On Oct. 15, 2024, Massachusetts Governor Maura Healey and the Massachusetts Life Sciences Center (MLSC) announced $21.4 million…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Life Science News | Neurology | NIH | Non-Profit Research | Therapeutics | Vaccine
Study Found Persistent Infection Could Explain Long COVID in Some People
On Oct. 9, 2024, researchers from Brigham and Women’s Hospital found that people with wide-ranging long COVID symptoms…
Nobel Prize in Physiology or Medicine awarded to Victor Ambros and Gary Ruvkun
On Oct. 7, 2024, The Nobel Foundation announced that Victor Ambros from Harvard University and Gary Ruvkun from…
Artificial Intelligence | Biotechnology | Life Science News | Non-Profit Research | Rare Disease | Therapeutics
Researchers used AI to Repurpose Existing Drugs for Treatment of Rare Diseases
On Sept. 25, 2024, a study led by scientists at Harvard Medical School announced they had developed an…
Biotechnology | Diagnostics | Life Science News | Medical Device | Non-Profit Research | Therapeutics
International Study Detected Consciousness in Unresponsive Patients
On Aug. 14, 2024, a study co-led by Mass General Brigham found that one in four patients with…
Lilly opened state-of-the-art research and development center in the Boston Seaport
On Aug. 13, 2024, Eli Lilly announced the opening of the Lilly Seaport Innovation Center (LSC), a research…
Moderna Received $176 million Award through BARDA to Accelerate Development of mRNA-based Pandemic Influenza Vaccine
On Jul. 2, 2024, Moderna announced a project award of $176 million through the Rapid Response Partnership Vehicle…
Moderna received U.S. FDA approval for RSV vaccine mRESVIA
On May 31, 2024, Moderna announced that the U.S. Food and Drug Administration (FDA) has approved mRESVIA (mRNA-1345),…
National Academies reported COVID-19 vaccines don’t cause many potential harms
On May 10, 2024, the National Academies of Sciences, Engineering, and Medicine reported that the COVID-19 vaccines made…
Moderna announced contract with Brazil to supply 12.5 million COVID-19 vaccines as part of national vaccination campaign
On Apr. 22, 2024, Moderna announced a contract with the Ministry of Health in Brazil (Ministerio da Saude)…
Biotechnology | CRISPR | Genomics | Life Science News | USDA
USDA-APHIS Determined Yield10 Bioscience’s Omega-3 Camelina Varieties May Be Planted and Bred in the U.S.
On Mar. 21, 2024, Yield10 Bioscience announced that USDA-APHIS’s Biotechnology Regulatory Services (“BRS”) has determined that Yield10’s Camelina…
In a first, genetically edited pig kidney was transplanted into a human
On Mar. 21, 2024, Harvard Medical School physician-scientists at Massachusetts General Hospital announced they had successfully transplanted a…
Eledon Pharma announced use of tegoprubart in first-ever transplant of genetically modified kidney from a pig to a human
On Mar. 21, 2024, Eledon Pharmaceuticals announced that tegoprubart, the company’s investigational anti-CD40L antibody, was used as a…
Moderna received U.S. FDA approval for updated COVID-19 vaccine
On Sept. 11, 2023, Moderna announced the U.S. Food and Drug Administration (FDA) had approved the supplemental Biologics…
Biotechnology | COVID-19 | FDA | Life Science News | Vaccine
Moderna clinical trial data confirmed updated Covid-19 vaccine generated strong immune response against BA.2.86 variant
On Sept. 6, 2023, Moderna announced that clinical trial data from its research assay confirmed its updated COVID-19…
MIT and two California universities received $50 million grant for Army research
On Aug. 27, 2003, The Institute for Collaborative Biotechnologies (ICB) announced it was funding a $50 million five…
Eye cell atlas pinpoints where disease-causing genes are expressed, raising hope for inroads against blindness
On Aug. 25, 2023, Harvardﾒs Center for Brain Science announced the ceation of an eye atlas that pinpoints…
Henrietta Lacks’ family settled lawsuit with biotech company that used her cells without consent
On Aug. 1, 2023, more than 70 years after doctors at Johns Hopkins Hospital took Henrietta Lacks’ cervical…
AquaBounty Announced a Pause to Ohio Farm Construction While It Evaluated Alternatives
On Jun. 22, 2023 AquaBounty Technologies announced that the Company will pause the construction of its farm in…